Фулвестрант Ever Pharma

Фулвестрант Ever Pharma is an intramuscular estrogen receptor antagonist used in hormone receptor-positive breast cancer treatment. This prescription medication works by blocking estrogen receptors to slow tumor growth. Seek medical guidance before use.

Fulvestrant is prescribed for hormone receptor-positive metastatic breast cancer in postmenopausal women. It is also used when cancer progresses after anti-estrogen therapy. Patients often ask, 'What is fulvestrant used for?' to understand its role in cancer management. The drug targets estrogen receptors to reduce tumor progression.

Fulvestrant may cause mild to moderate injection site reactions, including pain or swelling. Some users report hot flashes, nausea, or fatigue as common effects. These reactions vary by individual and are typically temporary. Always discuss persistent symptoms with a healthcare provider.

Fulvestrant should be handled with care by healthcare professionals due to its intramuscular route. Patients with bleeding disorders or infections at injection sites should inform their doctor. Pregnant individuals must avoid exposure to this medication. Store at controlled room temperature and protect from light.

Fulvestrant may interact with CYP3A4 inhibitors, potentially increasing its effects. Avoid alcohol and other medications that affect liver enzymes unless directed by a doctor. Patients using blood thinners should monitor for increased bleeding risks. Always disclose all medications to your healthcare provider.